Commit Biologics
Latest round
- Seed
Last raised
- Mar 2026
Total raised
- $48M
Investors
- 3
About Commit Biologics
Based in Aarhus, Denmark, and founded in 2021 by co-founders Nick S. Laursen, Dennis V. Pedersen, Heidi Gytz Olesen, and Mikael Winkler, Commit Biologics ApS operates as a biotechnology research company, that develops a novel immunotherapy platform for the treatment of cancer. Commit Biologics' portfolio is BiCE technology, a platform designed to activate the complement system against cancer cells. The company employs bi-specific antibodies to activate the complement cascade, facilitating targeted destruction of tumor cells while promoting an immune response against cancer. Its mechanism of action triggers tumor cell killing while also modulating the tumor microenvironment.
Who invested in Commit Biologics
3 investors across 3 rounds
See all investors in Commit Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Commit Biologics
Who invested in Commit Biologics?
Commit Biologics has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Commit Biologics raised?
Commit Biologics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Commit Biologics last raise money?
Commit Biologics's most recent round on record is a Seed, in Mar 2026.
What does Commit Biologics do?
Based in Aarhus, Denmark, and founded in 2021 by co-founders Nick S.
Where is Commit Biologics headquartered?
Commit Biologics is headquartered in Aarhus, Denmark.
Which VCs invest in companies like Commit Biologics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Commit Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Commit Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.